Advanced preformulation investigations for the development of a lead intravaginal bioadhesive polymeric device

References

• Garg S, Tambwekar KR. (2003). Development pharmaceutics of microbicide formulations Part II. Formulation, evaluation and challenges. AIDS Patient Care and STDs, 17:377–399.
   PubMed Web of Science ®Google Scholar
• das Neves J, Bahia MF. (2006). Gels as vaginal drug delivery systems. Int j Pharm, 318:1–14.
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Uckun FM. (2006). Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. j Antimicrob Chemother, 57:411–423.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. (2009). Mucoadhesive polymeric platforms for controlled drug delivery. Eur j Pharm Biopharm, 71:505–518.
   PubMed Web of Science ®Google Scholar
• Justin-Temu M, Damian F, Kinget R, Van Den Mooter G. (2004). Intravaginal gels as drug delivery systems. j Womens Health (Larchmt), 13:834–844.
   PubMed Web of Science ®Google Scholar
• Ndesendo VM, Pillay V, Choonara YE, Buchmann E, Bayever DN, Meyer LC. (2008). A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. aaps Pharmscitech, 9:505–520.
   PubMed Web of Science ®Google Scholar
• Rohan LC, Sassi AB. (2009). Vaginal drug delivery systems for HIV prevention. Aaps J, 11:78–87.
   PubMed Web of Science ®Google Scholar
• Sekimizu K, Kokudo N. (2008). Dug discoveries and therapeutics, 2, 4, [on line] Available at: http://www.ddtjournal.com/files/DDT_2008Vol2No4_pp200_261.pdf. Accessed on 1 March 2010.
   Google Scholar
• Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. (2004). Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur j Pharm Biopharm, 58:51–59.
   PubMed Web of Science ®Google Scholar
• Ravi PR, Kotreka UK, Saha RN. (2008). Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics. aaps Pharmscitech, 9:302–313.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Avgoustakis K. (2004). Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv, 1:321–333.
   PubMedGoogle Scholar
• Arifin DY, Lee LY, Wang CH. (2006). Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv Drug Deliv Rev, 58:1274–1325.
   PubMed Web of Science ®Google Scholar
• Pinto JF, Wunder KF, Okoloekwe A. (2004). Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material. Aaps J, 6:17–26.
   PubMedGoogle Scholar
• Hiremath PS, Saha RN. (2008). Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int j Pharm, 362:118–125.
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang Y, Xiao L, Zhao Z. (2008). optimization of extended zero-order release gliclazide tablets using D-optimal mixture design. Yakugaku Zasshi, 128:1475–1483.
   PubMed Web of Science ®Google Scholar
• Hasan EI, Amro BI, Arafat T, Badwan AA. (2003). Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl. Eur j Pharm Biopharm, 55:339–344.
   PubMed Web of Science ®Google Scholar
• Chopra S, Patil GV, Motwani SK. (2007). Release modulating hydrophilic matrix systems of losartan potassium: optimization of formulation using statistical experimental design. Eur j Pharm Biopharm, 66:73–82.
   PubMed Web of Science ®Google Scholar
• Rahman BM, Islam MA, Wahed MII, Ahmed M, Islam R, Barman K, Anisuzzaman ASM, Khondkar P. (2009). In vitro studies of pentoxifylline controlled-release from hydrophilic matrices. J Sci Res, 1, 2:353–362.
   Google Scholar
• Einmahl S, Capancioni S, Schwach-Abdellaoui K, Moeller M, Behar-Cohen F, Gurny R. (2001). Therapeutic applications of viscous and injectable poly(ortho esters). Adv Drug Deliv Rev, 53:45–73.
   PubMed Web of Science ®Google Scholar
• Breton P, Larras V, Roy D, Sagodira S, Limal D, Bonnafous D et al. (2008). Biocompatible poly(methylidene malonate)-made materials for pharmaceutical and biomedical applications. Eur j Pharm Biopharm, 68:479–495.
   PubMed Web of Science ®Google Scholar
• Barakat NS, Elbagory IM, Almurshedi AS. (2009). Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Drug Deliv, 16:57–65.
   PubMed Web of Science ®Google Scholar
• Nirmal M. (2006). Control release formulation containing a hydrophobic material as the sustained release agent. US Patent, 7052706 [on line] Available at: http://www.patentstorm.us/patents/7052706/description.html. Accessed on 9 June 2009.
   Google Scholar
• Khoee S, Hassanzadeh S, Goliaie B. (2007). Effects of hydrophobic drug-polyesteric core interactions on drug loading and release properties of poly (ethylene glycol) triblock core shell nanoparticles. Nanotechnology, 18:1–9.
   Web of Science ®Google Scholar
• Wu F, Jin T. (2008). Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances. aaps Pharmscitech, 9:1218–1229.
   PubMed Web of Science ®Google Scholar
• Smith RC, Leung A, Kim BS, Hammond PT. (2009). Hydrophobic Effects in the Critical Destabilization and Release Dynamics of Degradable Multilayer Films. Chem Mater, 21:1108–1115.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lafuente C, Teresa Faucci M, Fernández-Arévalo M, Alvarez-Fuentes J, Rabasco AM, Mura P. (2002). Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers. Int j Pharm, 234:213–221.
   PubMed Web of Science ®Google Scholar
• Sant S, Thommes M, Hildgen P. (2008). Microporous structure and drug release kinetics of polymeric nanoparticles. Langmuir, 24:280–287.
   PubMed Web of Science ®Google Scholar
• Yu DG, Branford-White C, Ma ZH, Zhu LM, Li XY, Yang XL. (2009). Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int j Pharm, 370:160–166.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang F, McGinity JW. (2001). Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur j Pharm Biopharm, 52:181–190.
   PubMed Web of Science ®Google Scholar
• Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. (2003). Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. aaps Pharmscitech, 4:E31.
   PubMedGoogle Scholar
• Garg S, Jambu L, Vermani K. (2007). Development of novel sustained release bioadhesive vaginal tablets of povidone iodine. Drug Dev Ind Pharm, 33:1340–1349.
   PubMed Web of Science ®Google Scholar
• Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692–1712.
   PubMed Web of Science ®Google Scholar
• Patel VF, Patel NM. (2007). Statistical evaluation of influence of xanthan gum and guar gum blends on dipyridamole release from floating matrix tablets. Drug Dev Ind Pharm, 33:327–334.
   PubMed Web of Science ®Google Scholar
• Barakat NS, Elbagory IM, Almurshedi AS. (2008). Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components. aaps Pharmscitech, 9:1054–1062.
   PubMed Web of Science ®Google Scholar
• Sibeko B, Pillay V, Choonara YE, Khan RA, Modi G, Iyuke SE et al. (2009). Computational molecular modeling and structural rationalization for the design of a drug-loaded PLLA/PVA biopolymeric membrane. Biomed Mater, 4:015014.
   Web of Science ®Google Scholar
• Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. (2001). Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. j Control Release, 70:383–391.
   PubMed Web of Science ®Google Scholar
• Christ KA, Zessin G., Cobet U. (1998). The use of ultrasound and penentrometer to characterize the advancement of swelling and eroding fronts in HPMC matrices. Int J Pharm, 163:123–131.
   Web of Science ®Google Scholar
• Al-Taani BM, Tashtoush BM. (2003). Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium. aaps Pharmscitech, 4:E43.
   PubMedGoogle Scholar
• Dahlberg C, Fureby A, Schuleit M, Dvinskikh SV, Furó I. (2007). Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study. j Control Release, 122:199–205.
   PubMed Web of Science ®Google Scholar
• Mehta KA, Kislalioglu MS, Phuapradit W, Malick AW, Shah NH. (2000). Effect of formulation and process variables on porosity parameters and release rates from a multi unit erosion matrix of a poorly soluble drug. j Control Release, 63:201–211.
   PubMed Web of Science ®Google Scholar
• Vlachou M, Naseef H, Efentakis M, Tarantili PA, Andreopoulos AG. (2001). Swelling properties of various polymers used in controlled release systems. j Biomater Appl, 15:293–306.
   PubMed Web of Science ®Google Scholar
• Haltrich D, Lavssamayer B, Steiner W. (1994). Xylanase formation by Sclerotium rolfsii effect of growth substrates and development of a culture medium using statistical designed experiments. Appl Microbiol Biotechnol 42:522–530.
   Web of Science ®Google Scholar
• He GQ, Chen QH, Ju XJ, Shi ND. (2004). Improved elastase production by Bacillus sp. EL31410–further optimization and kinetics studies of culture medium for batch fermentation. j Zhejiang Univ Sci, 5:149–156.
   PubMedGoogle Scholar
• Kolawole OA, Pillay V, Choonara YE. (2007). Novel polyamide 6,10 variants Synthesized by modified interfacial polymerization for application as a rate-modulated monolithic drug delivery System. J Bioact Compat Pol, 22:281–313.
   Web of Science ®Google Scholar
• D’Cruz OJ, Uckun FM. (2002). Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07). j Antimicrob Chemother, 50:793–803.
   PubMed Web of Science ®Google Scholar
• Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K et al. (1998). Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. n Engl j Med, 339:1803–1809.
   PubMed Web of Science ®Google Scholar
• Garg S, Verman K, Anderson RA, Zaneveld LJ. (2004). Rapidly disintegrating novel bioadhesive vaginal tablets of polystyrene sulfonate (PSS), a potential microbicide formulation. International Conference of AIDS. Abstract No. TuPeB4656 [on line] Available at: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102282478.html. Accessed on 12 November 2007.
   Google Scholar
• Richardson BA, Martin HL Jr, Stevens CE, Hillier SL, Mwatha AK, Chohan BH et al. (1998). Use of nonoxynol-9 and changes in vaginal lactobacilli. j Infect Dis, 178:441–445.
   PubMed Web of Science ®Google Scholar
• Rosenstein IJ, Stafford MK, Kitchen VS, Ward H, Weber JN, Taylor-Robinson D. (1998). Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. j Infect Dis, 177:1386–1390.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Feathergill K, Diao X, Cooper M, Kirkpatrick R, Spear P et al. (2000). Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases. j Androl, 21:862–875.
   PubMed Web of Science ®Google Scholar
• Simoes JA, Citron DM, Aroutcheva A, Anderson RA Jr, Chany CJ 2nd, Waller DP et al. (2002). Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis. Antimicrob Agents Chemother, 46:2692–2695.
   PubMed Web of Science ®Google Scholar
• Buddhikot M, Falkenstein E, Wehling M, Meizel S. (1999). Recognition of a human sperm surface protein involved in the progesterone-initiated acrosome reaction by antisera against an endomembrane progesterone binding protein from porcine liver. Mol Cell Endocrinol, 158:187–193.
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Villalobos-García R, Alvarez-Colín E, Cornejo-Bravo JM. (2001). In vitro evaluation of the bioadhesive properties of hydrophobic polybasic gels containing N,N-dimethylaminoethyl methacrylate-co-methyl methacrylate. Biomaterials, 22:957–961.
   PubMed Web of Science ®Google Scholar
• Sandri G, Rossi S, Ferrari F, Bonferoni MC, Muzzarelli C, Caramella C. (2004). Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur j Pharm Sci, 21:351–359.
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Erbeck D, Uckun FM. (2005). A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol Pathol, 33:465–476.
   PubMed Web of Science ®Google Scholar
• Owen DH, Katz DF. (2005). A review of the physical and chemical properties of human semen and the formulation of a semen simulant. j Androl, 26:459–469.
   PubMed Web of Science ®Google Scholar
• Owen DH, Katz DF. (1999). A vaginal fluid simulant. Contraception, 59:91–95.
   PubMed Web of Science ®Google Scholar
• Campo VL, Kawano DF, da Silva DB, Carvalho I. (2009).Carrageenans: Biological properties, chemical modifications and structural analysis − A review. Carbohydr. Polym, 77:167–180.
   Google Scholar
• Varma M, Singla AK, Dhawan S. (2004). Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev Ind Pharm, 30:545–553.
   PubMed Web of Science ®Google Scholar
• Yan C, Wu G, Lin S. (2006). Alkaline blend polymer electrolytes based on polyvinyl alcohol (PVA)/tetraethyl ammonium chloride (TEAC). J Appl Electrochem, 36:655–661.
   Web of Science ®Google Scholar
• Yang Y, Liu C, Wu H. (2008). Preparation and properties of poly(vinyl alcohol)/exfoliated α-zirconium phosphate nanocomposite films. Polym. Test, 28:371–377.
   Web of Science ®Google Scholar
• Mukherjee GS. (2009). Calorimetric characterization of membrane materials based on polyvinyl alcohol. J Therm Anal Calorim, 96:21–25.
   Web of Science ®Google Scholar
• Rodd AB, Dunstan DE, Boger DV. (2000). Characterisation of xanthan gum solutions using dynamic light scattering and rheology. Carbohydr Polym, 42, 159–174.
   Web of Science ®Google Scholar
• Iseki T, Takahashi M, Hattori H, Hatakeyama T, Hatakeyama H. (2001). Viscoelastic properties of xanthan gum hydrogels annealed in the sol state. Food and Hydrocolloids, 15:503–506.
   Web of Science ®Google Scholar
• Quinn FX, Hatakeyama T, Takahashi M, Hatakeyama H. (1994). The effect of annealing on the conformational properties of xanthan hydrogels. Polymer, 35:1248–1252.
   Web of Science ®Google Scholar
• Song K, Kim Y, Chang G. (2006). Rheology of concentrated xanthan gum solutions: Steady shear flow behavior. Fibers and Polymers, 7, 129–138.
   Web of Science ®Google Scholar
• Soukoulis C, Panagiotidis P, Koureli R, Tzia C. (2007). Industrial yogurt manufacture: monitoring of fermentation process and improvement of final product quality. J Dairy Sci, 90:2641–2654.
   PubMed Web of Science ®Google Scholar
• Billa N, Yuen KH. (2000). Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. aaps Pharmscitech, 1:E30.
   PubMedGoogle Scholar
• Ward G, Courts A. (1977). The science and technology of gelatin. London; New York: Academic Press, 1977 [on line] Available at: http://catalogue.nla.gov.au/Record/828694. Accessed on 24 August 2009.
   Google Scholar
• Baumgartner S, Kristl J, Peppas NA. (2002). Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium. Pharm Res, 19:1084–1090.
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. (2002). Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur j Pharm Sci, 16:53–61.
   PubMed Web of Science ®Google Scholar
• Ndesendo VM, Meixner W, Korsatko W, Korsatko-Wabnegg B. (1996). Microencapsulation of chloroquine diphosphate by Eudragit RS100. j Microencapsul, 13:1–8.
   PubMed Web of Science ®Google Scholar
• Wong CF, Yuen KH, Peh KK. (1999). Formulation and evaluation of controlled release Eudragit buccal patches. Int j Pharm, 178:11–22.
   PubMed Web of Science ®Google Scholar
• Trapani A, Laquintana V, Denora N, Lopedota A. (2007). Eudragit RS 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione: Physicochemical characterization, drug release and transport studies. Eur J Pharm Sci, 30:64–74.
   PubMed Web of Science ®Google Scholar
• Umamaheshwari RB, Ramteke S, Jain NK. (2004). Anti–Helicobacter Pylori Effect of Bioadhesive Nanoparticles Bearing Amoxicillin in Experimental Gerbils Model. AAPS Pharm Sci Tech, 5:2.
   Google Scholar
• Ndesendo VM, Pillay V, Choonara YE, Khan RA, Meyer L, Buchmann E et al. (2009). In vitro and ex vivo bioadhesivity analysis of polymeric intravaginal caplets using physicomechanics and computational structural modeling. Int j Pharm, 370:151–159.
   PubMed Web of Science ®Google Scholar
• Gimeno E, Moraru CI, Kokini JL. (2003) Effects of Xanthan gum and CMC on the structure and texture of corn flour pellets expanded by microwave heating. Cereal Chem, 81:100–107.
   Web of Science ®Google Scholar
• Guoqiang D, Batra R, Kaul R, Gupta MN, Mattiasson B. (1995). Alternative modes of precipitation of Eudragit S 100: a potential ligand carrier for affinity precipitation of protein. Bioseparation, 5:339–350.
   Google Scholar
• Arasaratnam V V, Galaev IY, Mattiasson B. (2000). Reversibly soluble biocatalyst: optimization of trypsin coupling to Eudragit S-100 and biocatalyst activity in soluble and precipitated forms. Enzyme Microb Technol, 27:254–263.
   PubMed Web of Science ®Google Scholar
• Girish KL, Dhiren PS. (2008). Evaluation of Mucilage of Hibiscus rosasinensis Linn as Rate Controlling Matrix for Sustained Release of Diclofenac. Drug Dev Ind Pharm, 34:807–816.
   PubMed Web of Science ®Google Scholar
• Wen X, Wang T, Wang Z, Li L, Zhao C. (2008). Preparation of konjac glucomannan hydrogels as DNA-controlled release matrix. Int j Biol Macromol, 42:256–263.
   PubMed Web of Science ®Google Scholar
• Jang SS, Goddard WA. (2007). Mechanical and Transport Properties of the Poly(ethylene oxide)-Poly(acrylic acid) Double Network Hydrogel from Molecular Dynamic Simulations. J Phys Chem B, 111:1729–1737.
   PubMed Web of Science ®Google Scholar